Agency Information Collection Activities: Proposed Collection; Comment Request, 76626-76628 [2022-27166]
Download as PDF
<![CDATA[
76626
Federal Register / Vol. 87, No. 240 / Thursday, December 15, 2022 / Notices
(OMB control number: 0938–0046);
Frequency: Yearly; Affected Public:
Private Sector (Business or other forprofits, Not-for-Profit Institutions);
Number of Respondents: 7,828; Total
Annual Responses: 138,000; Total
Annual Hours: 138,000. (For policy
questions regarding this collection
contact Lisa Rees at (816) 426–6353).
Dated: December 12, 2022.
William N. Parham, III
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–27233 Filed 12–14–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10527, CMS–
10260, CMS–10836 and CMS–855A]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 13, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:51 Dec 14, 2022
Jkt 259001
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10527 Annual Eligibility
Redetermination, Product
Discontinuation and Renewal
Notice
CMS–10260 Medicare Advantage and
Prescription Drug Program: Final
Marketing Provisions in 42 CFR
422.111(a)(3) and 423.128(a)(3)
CMS–10836 Medicare Plan Performance
Warning Information
CMS–855A Medicare Enrollment
Application for Institutional
Providers
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Annual
Eligibility Redetermination, Product
Discontinuation and Renewal Notice;
Use: Section 1411(f)(1)(B) of the
Affordable Care Act directs the
Secretary of Health and Human Services
(the Secretary) to establish procedures
to redetermine the eligibility of
individuals for premium tax credits on
a periodic basis in appropriate
circumstances. Section 1321(a) of the
Affordable Care Act provides authority
for the Secretary to establish standards
and regulations to implement the
statutory requirements related to
Exchanges, qualified health plans
(QHPs) and other components of title I
of the Affordable Care Act. Under
section 2703 of the Public Health
Service Act (PHS Act), as added by the
Affordable Care Act, and former section
2712 and section 2741 of the PHS Act,
enacted by the Health Insurance
Portability and Accountability Act of
1996, health insurance issuers in the
group and individual markets must
guarantee the renewability of coverage
unless an exception applies.
The 2014 final rule ‘‘Patient
Protection and Affordable Care Act;
Annual Eligibility Redeterminations for
Exchange Participation and Insurance
Affordability Programs; Health
Insurance Issuer Standards Under the
Affordable Care Act, Including
Standards Related to Exchanges’’ (79 FR
52994, September 5, 2014), provides
that an Exchange may choose to conduct
the annual redetermination process for
a plan year (1) in accordance with the
existing procedures described in 45 CFR
155.335; (2) in accordance with
procedures described in guidance
issued by the Secretary for the
applicable benefit year; or (3) using an
alternative procedure proposed by the
Exchange and approved by the
Secretary. The 2014 final rule
established a renewal and reenrollment
hierarchy at 45 CFR 155.335(j) to
minimize potential enrollment
disruptions. The 2016 final rule ‘‘Patient
Protection and Affordable Care Act;
HHS Notice of Benefit and Payment
Parameters for 2017’’ (81 FR 12204,
March 8, 2016) amended the enrollment
E:\FR\FM\15DEN1.SGM
15DEN1
Federal Register / Vol. 87, No. 240 / Thursday, December 15, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
hierarchy to further minimize potential
disruptions of enrollee eligibility for
cost-sharing reductions.
The guidance document ‘‘Guidance
on Annual Eligibility Redetermination
and Re-enrollment for Exchange
Coverage for 2019 and Later Years’’
contains the procedures that the
Secretary is specifying for the coverage
year, as noted in (2) above, and specifies
that these procedures will be used by all
Exchanges using the federal eligibility
and enrollment platform, unless
otherwise specified in future guidance
or rulemaking.
The 2014 final rule also amended the
requirements for product renewal and
re-enrollment (or non-renewal) notices
to be sent by QHP issuers in the
Exchanges and specifies content for
these notices. The guidance document
‘‘Updated Federal Standard Renewal
and Product Discontinuation Notices,
and Enforcement Safe Harbor for
Product Discontinuation Notices in
Connection with the Open Enrollment
Period for Coverage in the Individual
Market in the 2020 Benefit Year’’
provides standard notices for product
discontinuation and renewal to be sent
by issuers of individual market QHPs
and issuers in the individual market.1
The federal standard notices to be
sent by issuers of individual market
QHPs and issuers in the individual
market have been revised to improve
consumer understanding and update
out-of-date information. The revised
notices in this information collection
will be required for notices provided in
connection with coverage beginning in
the 2024 plan year.
Issuers in the small group market may
use the draft federal standard small
group notices released in the June 26,
2014 bulletin ‘‘Draft Standard Notices
When Discontinuing or Renewing a
Product in the Small Group or
Individual Market’’, or any forms of the
notice otherwise permitted by
applicable laws and regulations. States
that are enforcing the guaranteed
renewability provisions of the
Affordable Care Act may develop their
own standard notices for product
1 Updated Federal Standard Renewal and Product
Discontinuation Notices, and Enforcement Safe
Harbor for Product Discontinuation Notices in
Connection with the Open Enrollment Period for
Coverage in the Individual Market in the 2020
Benefit Year (July 30, 2019) available at: https://
www.cms.gov/CCIIO/Resources/Regulations-andGuidance/Downloads/Updated-Federal-StandardNotices-and-Enforcement-Safe-Harbor-forDiscontinuation-Notices-PY2020.pdf. This bulletin
was revised on July 31, 2020 to add a link to the
federal standard notices to be used beginning in the
2021 plan year: https://www.cms.gov/CCIIO/
Resources/Regulations-and-Guidance/Downloads/
Updated-Federal-Standard-Notices-for-coveragebeginning-in-the-2021-plan-year.pdf.
VerDate Sep<11>2014
16:51 Dec 14, 2022
Jkt 259001
discontinuances, renewals, or both,
provided the state-developed notices are
at least as protective as the federal
standard notices. Form Number: CMS–
10527 (OMB control number: 0938–
1254); Frequency: Annually; Affected
Public: Private Sector, State, Local, or
Tribal Governments; Number of
Respondents: 1,340; Total Annual
Responses: 5,881; Total Annual Hours:
72,147. (For policy questions regarding
this collection contact Usree
Bandyopadhyay at 410–786–6650.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage and Prescription Drug
Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3);
Use: CMS requires MA organizations
and Part D sponsors to use the
standardized documents being
submitted for OMB approval to satisfy
disclosure requirements mandated by
section 1851 (d)(3)(A) of the Act and
§ 422.111 for MA organizations and
section 1860D–1(c) of the Act and
§ 423.128(a)(3) for Part D sponsors. The
regulatory provisions at §§ 422.111(b)
and 423.128(b) require MA
organizations and Part D sponsors to
disclose plan information, including:
service area, benefits, access, grievance
and appeals procedures, and quality
improvement/assurance requirements.
MA organizations and sponsors may
send the ANOC separately from the
EOC, but must send the ANOC for
enrollee receipt by September 30. The
required due date for the EOC is 15 days
prior to the start of the AEP.
CMS requires MA organization and
Part D sponsors to submit marketing
materials to CMS for review prior to the
MA organization or sponsor distributing
those materials to the public. In section
1851(h), paragraphs (1), (2), and (3)
establish this requirement for MA
organizations. Section 1860D–
1(b)(1)(B)(vi) directs Part D sponsors to
follow the same requirements in section
1851(h) that MA organizations must
follow for this purpose. Form number:
CMS–10260 (OMB control number:
0938–1051); Frequency: Annually;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
800; Number of Responses: 48,439;
Total Burden Hours: 13,568. (For
questions regarding this collection
contact Elizabeth Jacob at 410–786–
8658).
3. Type of Information Collection
Request: New collection (Request for
new OMB control number); Title of
Information Collection: Medicare Plan
Performance Warning Information; Use:
The Centers for Medicare & Medicaid
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
76627
Services (CMS) is seeking approval to
collect information to assist in the
Agency’s response to two reports from
the Department of Health and Human
Services Office of the Inspector General
(OIG) related to how the agency conveys
information on plan performance.
CMS is conducting this research to
respond to OIG’s recommendations
related to sharing additional
information with beneficiaries on plan
performance in a clear and accessible
format, particularly related to
information which may warn or caution
beneficiaries about plan performance
issues. CMS is seeking to learn more
about how beneficiaries, caregivers, and
the intermediaries who assist them use
and understand the information CMS
currently makes (or may make)
available, as well as to assess their
interest in accessing this information.
Form number: CMS–10836 (OMB
control number: 0938–New); Frequency:
Annually; Affected Public: Individuals
and Households; Number of
Respondents: 288; Number of
Responses: 288; Total Burden Hours:
497. (For questions regarding this
collection contact Elizabeth Goldstein at
443 845–6993).
4. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Enrollment Application for Institutional
Providers; Use: The primary function of
the CMS–855A Medicare enrollment
application is to gather information
from a certified provider or certified
supplier that tells us who it is, whether
it meets certain qualifications to be a
health care provider, where it practices
or renders services, the identity of its
owners, and other information
necessary to establish correct claims
payments.
In addition, on July 26, 2022, CMS
published in the Federal Register a
proposed rule titled ‘‘Medicare Program:
Hospital Outpatient Prospective
Payment and Ambulatory Surgical
Center Payment Systems and Quality
Reporting Programs; Organ Acquisition;
Rural Emergency Hospitals: Payment
Policies, Conditions of Participation,
Provider Enrollment, Physician SelfReferral; New Service Category for
Hospital Outpatient Department Prior
Authorization Process; Overall Hospital
Quality Star Rating’’ (CMS–1772–P) (87
FR 44502). This proposed rule outlined
requirements that rural emergency
hospitals (REHs)—a new Medicare
provider type established pursuant to
Section 125 of Division CC of the
Consolidated Appropriations Act,
2021—must meet in order to bill
Medicare for REH services. This
E:\FR\FM\15DEN1.SGM
15DEN1
76628
Federal Register / Vol. 87, No. 240 / Thursday, December 15, 2022 / Notices
information collection request addresses
the burden associated with the
completion of the applicable CMS–855A
by REHs in order to enroll in Medicare.
As part of this request, and as
described in the supporting statement,
we also seek approval for additional
changes to the CMS–855A. These
changes principally (though not
exclusively) involve the collection of
information related to the provider’s
ownership. Form Number: CMS–855A
(OMB control number: 0938–0685);
Frequency: On occasion; Affected
Public: Business or other for-profits, notfor-profit institutions; Number of
Respondents: 1,340; Total Annual
Responses: 5,881; Total Annual Hours:
72,147. (For policy questions regarding
this collection contact Frank Whelan at
410–786–1302.)
Dated: December 9, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–27166 Filed 12–14–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–3728]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Collection of
Conflict-of-Interest Information for
Participation in Food and Drug
Administration Non-Employee
Fellowship and Traineeship Programs
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments
(including recommendations) on the
collection of information by January 17,
2023.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
Review—Open for Public Comments’’ or
by using the search function. The OMB
control number for this information
collection is 0910–0882. Also include
the FDA docket number found in
brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–8867, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUMMARY:
Collection of Conflict-of-Interest
Information for Participation in Food
and Drug Administration NonEmployee Fellowship and Traineeship
Programs
OMB Control Number 0910–0882—
Extension
Section 742(b) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C.
379l(b)) allows FDA to conduct and
support intramural training programs
through fellowship and traineeship
programs. Prospective participants in
these programs must complete financial
disclosure forms to determine if there is
a conflict of interest that would
preclude participation. These new forms
provide FDA with information about
financial investments and relationships
from non-employee scientists who
participate in FDA fellowship and
traineeship programs. Participants in
FDA fellowship and traineeship
programs will be asked for certain
information about financial interests
and current relationships: (1)
description of the financial interest; (2)
the type of financial interest (e.g.,
stocks, bonds, stock options); (3) if the
financial interest is an employee benefit
from prior employment; (4) value of
financial interest; (5) who owns the
financial interest (e.g., self, spouse,
minor children); (6) employment
relationship with an FDA significantly
regulated organization (SRO); and (7)
service as a consultant to an FDA SRO,
and/or proprietary interest(s) in one of
more product(s) regulated by FDA,
including a patent, trademark,
copyright, or licensing agreement. The
purpose of the financial information is
for FDA to determine if there is a
conflict of interest between the Fellow’s
or Trainee’s financial and relationship
interests and their activities at FDA. The
collection of information is mandatory
to participate in FDA’s fellowship and
traineeship programs.
In the Federal Register of July 7, 2022
(87 FR 40537), FDA published a 60-day
notice requesting public comment on
the proposed collection of information.
Although one comment was received, it
was not responsive to the four collection
of information topics solicited.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Total annual
responses
Average
burden per
response
Total hours
Oak Ridge Institute for Science and Education Fellowship
Traineeship Program ...........................................................
Reagan Udall Fellowship at FDA ........................................
500
500
50
1
1
1
500
500
50
1
1
1
500
500
50
Total ..............................................................................
........................
........................
........................
........................
1,050
1 There
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
are no capital costs or operating and maintenance costs associated with this collection of information.
Based on a review of the information
collection since our last request for
VerDate Sep<11>2014
16:51 Dec 14, 2022
Jkt 259001
OMB approval, we have made no
adjustments to our burden estimate.
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
E:\FR\FM\15DEN1.SGM
15DEN1
]]>Agencies
[Federal Register Volume 87, Number 240 (Thursday, December 15, 2022)]
[Notices]
[Pages 76626-76628]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27166]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-10527, CMS-10260, CMS-10836 and CMS-855A]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by February 13, 2023.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10527 Annual Eligibility Redetermination, Product Discontinuation
and Renewal Notice
CMS-10260 Medicare Advantage and Prescription Drug Program: Final
Marketing Provisions in 42 CFR 422.111(a)(3) and 423.128(a)(3)
CMS-10836 Medicare Plan Performance Warning Information
CMS-855A Medicare Enrollment Application for Institutional Providers
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Annual
Eligibility Redetermination, Product Discontinuation and Renewal
Notice; Use: Section 1411(f)(1)(B) of the Affordable Care Act directs
the Secretary of Health and Human Services (the Secretary) to establish
procedures to redetermine the eligibility of individuals for premium
tax credits on a periodic basis in appropriate circumstances. Section
1321(a) of the Affordable Care Act provides authority for the Secretary
to establish standards and regulations to implement the statutory
requirements related to Exchanges, qualified health plans (QHPs) and
other components of title I of the Affordable Care Act. Under section
2703 of the Public Health Service Act (PHS Act), as added by the
Affordable Care Act, and former section 2712 and section 2741 of the
PHS Act, enacted by the Health Insurance Portability and Accountability
Act of 1996, health insurance issuers in the group and individual
markets must guarantee the renewability of coverage unless an exception
applies.
The 2014 final rule ``Patient Protection and Affordable Care Act;
Annual Eligibility Redeterminations for Exchange Participation and
Insurance Affordability Programs; Health Insurance Issuer Standards
Under the Affordable Care Act, Including Standards Related to
Exchanges'' (79 FR 52994, September 5, 2014), provides that an Exchange
may choose to conduct the annual redetermination process for a plan
year (1) in accordance with the existing procedures described in 45 CFR
155.335; (2) in accordance with procedures described in guidance issued
by the Secretary for the applicable benefit year; or (3) using an
alternative procedure proposed by the Exchange and approved by the
Secretary. The 2014 final rule established a renewal and reenrollment
hierarchy at 45 CFR 155.335(j) to minimize potential enrollment
disruptions. The 2016 final rule ``Patient Protection and Affordable
Care Act; HHS Notice of Benefit and Payment Parameters for 2017'' (81
FR 12204, March 8, 2016) amended the enrollment
[[Page 76627]]
hierarchy to further minimize potential disruptions of enrollee
eligibility for cost-sharing reductions.
The guidance document ``Guidance on Annual Eligibility
Redetermination and Re-enrollment for Exchange Coverage for 2019 and
Later Years'' contains the procedures that the Secretary is specifying
for the coverage year, as noted in (2) above, and specifies that these
procedures will be used by all Exchanges using the federal eligibility
and enrollment platform, unless otherwise specified in future guidance
or rulemaking.
The 2014 final rule also amended the requirements for product
renewal and re-enrollment (or non-renewal) notices to be sent by QHP
issuers in the Exchanges and specifies content for these notices. The
guidance document ``Updated Federal Standard Renewal and Product
Discontinuation Notices, and Enforcement Safe Harbor for Product
Discontinuation Notices in Connection with the Open Enrollment Period
for Coverage in the Individual Market in the 2020 Benefit Year''
provides standard notices for product discontinuation and renewal to be
sent by issuers of individual market QHPs and issuers in the individual
market.\1\
---------------------------------------------------------------------------
\1\ Updated Federal Standard Renewal and Product Discontinuation
Notices, and Enforcement Safe Harbor for Product Discontinuation
Notices in Connection with the Open Enrollment Period for Coverage
in the Individual Market in the 2020 Benefit Year (July 30, 2019)
available at: https://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/Updated-Federal-Standard-Notices-and-Enforcement-Safe-Harbor-for-Discontinuation-Notices-PY2020.pdf. This bulletin
was revised on July 31, 2020 to add a link to the federal standard
notices to be used beginning in the 2021 plan year: https://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/Updated-Federal-Standard-Notices-for-coverage-beginning-in-the-2021-plan-year.pdf.
---------------------------------------------------------------------------
The federal standard notices to be sent by issuers of individual
market QHPs and issuers in the individual market have been revised to
improve consumer understanding and update out-of-date information. The
revised notices in this information collection will be required for
notices provided in connection with coverage beginning in the 2024 plan
year.
Issuers in the small group market may use the draft federal
standard small group notices released in the June 26, 2014 bulletin
``Draft Standard Notices When Discontinuing or Renewing a Product in
the Small Group or Individual Market'', or any forms of the notice
otherwise permitted by applicable laws and regulations. States that are
enforcing the guaranteed renewability provisions of the Affordable Care
Act may develop their own standard notices for product discontinuances,
renewals, or both, provided the state-developed notices are at least as
protective as the federal standard notices. Form Number: CMS-10527 (OMB
control number: 0938-1254); Frequency: Annually; Affected Public:
Private Sector, State, Local, or Tribal Governments; Number of
Respondents: 1,340; Total Annual Responses: 5,881; Total Annual Hours:
72,147. (For policy questions regarding this collection contact Usree
Bandyopadhyay at 410-786-6650.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage and Prescription Drug Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3); Use: CMS requires MA
organizations and Part D sponsors to use the standardized documents
being submitted for OMB approval to satisfy disclosure requirements
mandated by section 1851 (d)(3)(A) of the Act and Sec. 422.111 for MA
organizations and section 1860D-1(c) of the Act and Sec. 423.128(a)(3)
for Part D sponsors. The regulatory provisions at Sec. Sec. 422.111(b)
and 423.128(b) require MA organizations and Part D sponsors to disclose
plan information, including: service area, benefits, access, grievance
and appeals procedures, and quality improvement/assurance requirements.
MA organizations and sponsors may send the ANOC separately from the
EOC, but must send the ANOC for enrollee receipt by September 30. The
required due date for the EOC is 15 days prior to the start of the AEP.
CMS requires MA organization and Part D sponsors to submit
marketing materials to CMS for review prior to the MA organization or
sponsor distributing those materials to the public. In section 1851(h),
paragraphs (1), (2), and (3) establish this requirement for MA
organizations. Section 1860D-1(b)(1)(B)(vi) directs Part D sponsors to
follow the same requirements in section 1851(h) that MA organizations
must follow for this purpose. Form number: CMS-10260 (OMB control
number: 0938-1051); Frequency: Annually; Affected Public: State, Local,
or Tribal Governments; Number of Respondents: 800; Number of Responses:
48,439; Total Burden Hours: 13,568. (For questions regarding this
collection contact Elizabeth Jacob at 410-786-8658).
3. Type of Information Collection Request: New collection (Request
for new OMB control number); Title of Information Collection: Medicare
Plan Performance Warning Information; Use: The Centers for Medicare &
Medicaid Services (CMS) is seeking approval to collect information to
assist in the Agency's response to two reports from the Department of
Health and Human Services Office of the Inspector General (OIG) related
to how the agency conveys information on plan performance.
CMS is conducting this research to respond to OIG's recommendations
related to sharing additional information with beneficiaries on plan
performance in a clear and accessible format, particularly related to
information which may warn or caution beneficiaries about plan
performance issues. CMS is seeking to learn more about how
beneficiaries, caregivers, and the intermediaries who assist them use
and understand the information CMS currently makes (or may make)
available, as well as to assess their interest in accessing this
information. Form number: CMS-10836 (OMB control number: 0938-New);
Frequency: Annually; Affected Public: Individuals and Households;
Number of Respondents: 288; Number of Responses: 288; Total Burden
Hours: 497. (For questions regarding this collection contact Elizabeth
Goldstein at 443 845-6993).
4. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Enrollment Application for Institutional Providers; Use: The primary
function of the CMS-855A Medicare enrollment application is to gather
information from a certified provider or certified supplier that tells
us who it is, whether it meets certain qualifications to be a health
care provider, where it practices or renders services, the identity of
its owners, and other information necessary to establish correct claims
payments.
In addition, on July 26, 2022, CMS published in the Federal
Register a proposed rule titled ``Medicare Program: Hospital Outpatient
Prospective Payment and Ambulatory Surgical Center Payment Systems and
Quality Reporting Programs; Organ Acquisition; Rural Emergency
Hospitals: Payment Policies, Conditions of Participation, Provider
Enrollment, Physician Self-Referral; New Service Category for Hospital
Outpatient Department Prior Authorization Process; Overall Hospital
Quality Star Rating'' (CMS-1772-P) (87 FR 44502). This proposed rule
outlined requirements that rural emergency hospitals (REHs)--a new
Medicare provider type established pursuant to Section 125 of Division
CC of the Consolidated Appropriations Act, 2021--must meet in order to
bill Medicare for REH services. This
[[Page 76628]]
information collection request addresses the burden associated with the
completion of the applicable CMS-855A by REHs in order to enroll in
Medicare.
As part of this request, and as described in the supporting
statement, we also seek approval for additional changes to the CMS-
855A. These changes principally (though not exclusively) involve the
collection of information related to the provider's ownership. Form
Number: CMS-855A (OMB control number: 0938-0685); Frequency: On
occasion; Affected Public: Business or other for-profits, not-for-
profit institutions; Number of Respondents: 1,340; Total Annual
Responses: 5,881; Total Annual Hours: 72,147. (For policy questions
regarding this collection contact Frank Whelan at 410-786-1302.)
Dated: December 9, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2022-27166 Filed 12-14-22; 8:45 am]
BILLING CODE 4120-01-P
